Selected research
Market Outlook & Growth Opportunities
Global Bovine Mastitis Market Outlook and Growth Opportunities 2026
Market perspective
The global Bovine Mastitis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Bovine Mastitis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Bovine Mastitis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Bovine Mastitis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Bovine Mastitis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Bovine Mastitis market include Zoetis, Bayer, West Way Health, MSD Animal Health, Elanco, Ceva and Boehringer Ingelheim International, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Bovine Mastitis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Bovine Mastitis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Bovine Mastitis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Bovine Mastitis market.
Bovine Mastitis Segment by Company
Zoetis
Bayer
West Way Health
MSD Animal Health
Elanco
Ceva
Boehringer Ingelheim International
Bovine Mastitis Segment by Type
Antibiotics
Others
Bovine Mastitis Segment by Application
Lactating Period
Dry Period
Bovine Mastitis Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global Bovine Mastitis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Bovine Mastitis key companies, revenue, market share, and recent developments.
3. To split the Bovine Mastitis breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Bovine Mastitis market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Bovine Mastitis significant trends, drivers, influence factors in global and regions.
6. To analyze Bovine Mastitis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bovine Mastitis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bovine Mastitis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bovine Mastitis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bovine Mastitis industry.
Chapter 3: Detailed analysis of Bovine Mastitis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Bovine Mastitis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Bovine Mastitis in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Antibiotics
- Others
Applications
- Lactating Period
- Dry Period
Companies covered
- Zoetis
- Bayer
- West Way Health
- MSD Animal Health
- Elanco
- Ceva
- Boehringer Ingelheim International
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Bovine Mastitis Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Bovine Mastitis Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Bovine Mastitis Market Dynamics
- 2.1 Bovine Mastitis Industry Trends
- 2.2 Bovine Mastitis Industry Drivers
- 2.3 Bovine Mastitis Industry Opportunities and Challenges
- 2.4 Bovine Mastitis Industry Restraints
3 Bovine Mastitis Market by Company
- 3.1 Global Bovine Mastitis Company Revenue Ranking in 2025
- 3.2 Global Bovine Mastitis Revenue by Company (2021-2026)
- 3.3 Global Bovine Mastitis Company Ranking (2024-2026)
- 3.4 Global Bovine Mastitis Company Manufacturing Base and Headquarters
- 3.5 Global Bovine Mastitis Company Product Type and Application
- 3.6 Global Bovine Mastitis Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Bovine Mastitis Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Bovine Mastitis Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Bovine Mastitis Market by Type
- 4.1 Bovine Mastitis Type Introduction
- 4.1.1 Antibiotics
- 4.1.2 Others
- 4.2 Global Bovine Mastitis Sales Value by Type
- 4.2.1 Global Bovine Mastitis Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Bovine Mastitis Sales Value by Type (2021-2032)
- 4.2.3 Global Bovine Mastitis Sales Value Share by Type (2021-2032)
5 Bovine Mastitis Market by Application
- 5.1 Bovine Mastitis Application Introduction
- 5.1.1 Lactating Period
- 5.1.2 Dry Period
- 5.2 Global Bovine Mastitis Sales Value by Application
- 5.2.1 Global Bovine Mastitis Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Bovine Mastitis Sales Value by Application (2021-2032)
- 5.2.3 Global Bovine Mastitis Sales Value Share by Application (2021-2032)
6 Bovine Mastitis Regional Value Analysis
- 6.1 Global Bovine Mastitis Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Bovine Mastitis Sales Value by Region (2021-2032)
- 6.2.1 Global Bovine Mastitis Sales Value by Region: 2021-2026
- 6.2.2 Global Bovine Mastitis Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Bovine Mastitis Sales Value (2021-2032)
- 6.3.2 North America Bovine Mastitis Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Bovine Mastitis Sales Value (2021-2032)
- 6.4.2 Europe Bovine Mastitis Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Bovine Mastitis Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Bovine Mastitis Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Bovine Mastitis Sales Value (2021-2032)
- 6.6.2 South America Bovine Mastitis Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Bovine Mastitis Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Bovine Mastitis Sales Value Share by Country, 2025 VS 2032
7 Bovine Mastitis Country-level Value Analysis
- 7.1 Global Bovine Mastitis Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Bovine Mastitis Sales Value by Country (2021-2032)
- 7.2.1 Global Bovine Mastitis Sales Value by Country (2021-2026)
- 7.2.2 Global Bovine Mastitis Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.7.2 France Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.14.2 China Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.17.2 India Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Bovine Mastitis Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Bovine Mastitis Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Bovine Mastitis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Zoetis
- 8.1.1 Zoetis Company Information
- 8.1.2 Zoetis Business Overview
- 8.1.3 Zoetis Bovine Mastitis Revenue and Gross Margin (2021-2026)
- 8.1.4 Zoetis Bovine Mastitis Product Portfolio
- 8.1.5 Zoetis Recent Developments
- 8.2 Bayer
- 8.2.1 Bayer Company Information
- 8.2.2 Bayer Business Overview
- 8.2.3 Bayer Bovine Mastitis Revenue and Gross Margin (2021-2026)
- 8.2.4 Bayer Bovine Mastitis Product Portfolio
- 8.2.5 Bayer Recent Developments
- 8.3 West Way Health
- 8.3.1 West Way Health Company Information
- 8.3.2 West Way Health Business Overview
- 8.3.3 West Way Health Bovine Mastitis Revenue and Gross Margin (2021-2026)
- 8.3.4 West Way Health Bovine Mastitis Product Portfolio
- 8.3.5 West Way Health Recent Developments
- 8.4 MSD Animal Health
- 8.4.1 MSD Animal Health Company Information
- 8.4.2 MSD Animal Health Business Overview
- 8.4.3 MSD Animal Health Bovine Mastitis Revenue and Gross Margin (2021-2026)
- 8.4.4 MSD Animal Health Bovine Mastitis Product Portfolio
- 8.4.5 MSD Animal Health Recent Developments
- 8.5 Elanco
- 8.5.1 Elanco Company Information
- 8.5.2 Elanco Business Overview
- 8.5.3 Elanco Bovine Mastitis Revenue and Gross Margin (2021-2026)
- 8.5.4 Elanco Bovine Mastitis Product Portfolio
- 8.5.5 Elanco Recent Developments
- 8.6 Ceva
- 8.6.1 Ceva Company Information
- 8.6.2 Ceva Business Overview
- 8.6.3 Ceva Bovine Mastitis Revenue and Gross Margin (2021-2026)
- 8.6.4 Ceva Bovine Mastitis Product Portfolio
- 8.6.5 Ceva Recent Developments
- 8.7 Boehringer Ingelheim International
- 8.7.1 Boehringer Ingelheim International Company Information
- 8.7.2 Boehringer Ingelheim International Business Overview
- 8.7.3 Boehringer Ingelheim International Bovine Mastitis Revenue and Gross Margin (2021-2026)
- 8.7.4 Boehringer Ingelheim International Bovine Mastitis Product Portfolio
- 8.7.5 Boehringer Ingelheim International Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst